Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host

Inflammatory Bowel Diseases

Volumn 17, Issue 9, 2011, Pages 1971-1978

  Strauss, Jaclyn ^a   Kaplan, Gilaad G ^b   Beck, Paul L ^b   Rioux, Kevin ^b   Panaccione, Remo ^b   Devinney, Rebekah ^b   Lynch, Tarah ^b   Allen Vercoe, Emma ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

bacterial invasion; fusobacteria; Fusobacterium nucleatum

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CANCER SCREENING; CELL ASSAY; CELL INVASION; CELL STRAIN CACO 2; COLITIS; COLON BIOPSY; COLON CANCER; CONTROLLED STUDY; CROHN DISEASE; FEMALE; FUSOBACTERIUM; FUSOBACTERIUM GONIDIAFORMANS; FUSOBACTERIUM NAVIFORME; FUSOBACTERIUM NECROPHORUM; FUSOBACTERIUM NUCLEATUM; FUSOBACTERIUM PERIODONTICUM; FUSOBACTERIUM VARIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; INDETERMINATE COLITIS; INTESTINE MUCOSA; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; SPECIES INVASION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; CACO-2 CELLS; CASE-CONTROL STUDIES; CELLS, CULTURED; COLONOSCOPY; FEMALE; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; MOUTH MUCOSA; PROGNOSIS; YOUNG ADULT;

EID: 79959474060     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21606     Document Type: Article

References (36)

1. Sartor RB,. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008; 134: 577-594. (Pubitemid 351173057)
2. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998; 115: 1405-1413. (Pubitemid 28545991)
3. Petersen AM, Nielsen EM, Litrup E, et al. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease. BMC Microbiol. 2009; 9: 171.
4. Ohkusa T, Okayasu I, Ogihara T, et al. Induction of experimental ulcerative colitis by Fusobacterium varium isolated from colonic mucosa of patients with ulcerative colitis. Gut. 2003; 52: 79-83. (Pubitemid 36020770)
5. Moore WE, Moore LV,. The bacteria of periodontal diseases. Periodontol 2000. 1994; 5: 66-77.
6. Strauss J, White A, Ambrose C, et al. Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. Anaerobe. 2008; 14: 301-309.
7. Han YW, Shi W, Huang GT, et al. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun. 2000; 68: 3140-3146. (Pubitemid 30340401)
8. Brazier JS, Citron DM, Goldstein EJ,. A selective medium for Fusobacterium spp. J Appl Bacteriol. 1991; 71: 343-346.
9. Baker GC, Smith JJ, Cowan DA,. Review and re-analysis of domain-specific 16S primers. J Microbiol Methods. 2003; 55: 541-555. (Pubitemid 37357207)
10. Bakken V, Aarø S, Hofstad T, et al. Outer membrane proteins as major antigens of Fusobacterium nucleatum. FEMS Microbiol Immunol. 1989; 1: 473-483.
11. Thurnheer T, Guggenheim B, Gruica B, et al. Infinite serovar and ribotype heterogeneity among oral Fusobacterium nucleatum strains? Anaerobe. 1999; 5: 79-92. (Pubitemid 29431599)
12. Goosney DL, Celli J, Kenny B, et al. Enteropathogenic Escherichia coli inhibits phagocytosis. Infect Immun. 1999; 67: 490-495. (Pubitemid 29059178)
13. Fredricks DN, Schubert MM, Myerson D,. Molecular identification of an invasive gingival bacterial community. Clin Infect Dis. 2005; 41: e1-4.
14. Matsuo T, Shirakami T, Ozaki K, et al. An immunohistological study of the localization of bacteria invading root pulpal walls of teeth with periapical lesions. J Endod. 2003; 29: 194-200. (Pubitemid 43210850)
15. Gmür R, Munson M, Wade W,. Genotypic and phenotypic characterization of fusobacteria from Chinese and European patients with inflammatory periodontal diseases. System Appl Microbiol. 2006; 29: 120-30. (Pubitemid 43197809)
16. Gharbia SE, Shah HN, Lawson PA, et al. Distribution and frequency of Fusobacterium nucleatum subspecies in the human oral cavity. Oral Microbiol Immunol. 1990; 5: 324-327.
17. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature. 2007; 449: 804-810. (Pubitemid 47598620)
18. Citron DM,. Update on the taxonomy and clinical aspects of the genus fusobacterium. Clin Infect Dis. 2002; 35: S22-27.
19. Han YW, Ikegami A, Rajanna C, et al. Identification and characterization of a novel adhesin unique to oral fusobacteria. J Bacteriol. 2005; 187: 5330-5340. (Pubitemid 41022952)
20. Uitto VJ, Baillie D, Wu Q, et al. Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect Immun. 2005; 73: 1171-1179. (Pubitemid 40165777)
21. Bachrach G, Ianculovici C, Naor R, et al. Fluorescence based measurements of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to mammalian cells. FEMS Microbiol Lett. 2005; 248: 235-240. (Pubitemid 40942133)
22. Ledder RG, Timperley AS, Friswell MK, et al. Coaggregation between and among human intestinal and oral bacteria. FEMS Microbiol Ecol. 2008; 66: 630-636.
23. Kang MS, Na HS, Oh JS,. Coaggregation ability of Weissella cibaria isolates with Fusobacterium nucleatum and their adhesiveness to epithelial cells. FEMS Microbiol Lett. 2005; 253: 323-329.
24. Bartold PM, Gully NJ, Zilm PS, et al. Identification of components in Fusobacterium nucleatum chemostat-culture supernatants that are potent inhibitors of human gingival fibroblast proliferation. J Periodontal Res. 1991; 26: 314-322.
25. McGuckin MA, Eri R, Simms LA, et al. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2009; 15: 100-113.
26. Edwards AM, Grossman TJ, Rudney JD,. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells. Infect Immun. 2006; 74: 654-662. (Pubitemid 43023121)
27. Gursoy UK, Könönen E, Uitto VJ,. Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells. Apmis. 2008; 116: 1063-1070.
28. Diaz PI, Zilm PS, Rogers AH,. The response to oxidative stress of Fusobacterium nucleatum grown in continuous culture. FEMS Microbiol Lett. 2000; 187: 31-34. (Pubitemid 30316451)
29. Silva VL, Diniz CG, Cara DC, et al. Enhanced pathogenicity of Fusobacterium nucleatum adapted to oxidative stress. Microb Pathog. 2005; 39: 131-138. (Pubitemid 41413260)
30. Swidsinski A, Doerffel Y, Loening-Baucke V, et al. Acute appendicitis is characterized by local invasion with Fusobacterium nucleatum/necrophorum. Gut. 2010 [Epub ahead of print].
31. Gophna U, Sommerfeld K, Gophna S, et al. Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis. J Clin Microbiol. 2006; 44: 4136-4141. (Pubitemid 44737260)
32. Manichanh C, Rigottier-Gois L, Bonnaud E, et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut. 2006; 55: 205-211. (Pubitemid 43117279)
33. Sepehri S, Kotlowski R, Bernstein CN, et al. Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis. 2007; 13: 675-683. (Pubitemid 46909981)
34. Frank DN, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007; 104: 13780-13785. (Pubitemid 350003397)
35. Ohkusa T, Sato N, Ogihara T, et al. Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gastroenterol Hepatol. 2002; 17: 849-853.
36. Neut C, Bulois P, Desreumaux P, et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol. 2002; 97: 939-946. (Pubitemid 34408252)